Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment

The rate of cognitive decline among patients with amnestic mild cognitive impairment (aMCI) varies, and it is thus crucial to accurately predict the probability of cognitive deterioration in patients with MCI. We compared the potential of cytokines with amyloid beta (Aβ) and tau biomarkers for predi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Aging Neurosci
Hauptverfasser: Liang, Chih-Sung, Tsai, Chia-Lin, Lin, Guan-Yu, Lee, Jiunn-Tay, Lin, Yu-Kai, Chu, Che-Sheng, Sung, Yueh-Feng, Tsai, Chia-Kuang, Yeh, Ta-Chuan, Chu, Hsuan-Te, Su, Ming-Wei, Yang, Fu-Chi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Neuroscience
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193360/
https://ncbi.nlm.nih.gov/pubmed/34122046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2021.670115
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge